ARCT vs IT · rev $152.3M vs P/E 16, rev $6.27B
Arcturus Therapeutics Holdings Inc (ARCT) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ARCT revenue for 2024-12-31 was $152.3M. Net income was -$80.9M. Revenue was down 8.7% from 2023-12-31 to 2024-12-31. ARCT currently screens at market cap $369.4M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ARCT currently screens at market cap $369.4M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ARCT and IT stock pages for the full models.
Not investment advice.